Indian industry, led by pharmaceutical companies, shared plans of investing $20.5 billion in the US at the 2026 SelectUSA Investment Summit, reinforcing the growing role of Indian companies as investors and partners in the US economy, per a statement issued by the US Mission in India on Wednesday.
“Under President Donald Trump’s leadership investment is flowing back into the US at record levels! Indian companies plan to invest over $20.5 billion in various sectors including tech, manufacturing and pharmaceuticals. This includes the 12 Indian companies who announced $1.1 billion in investments just today!” said Sergio Gor, US Ambassador to India, in a social media post.
As much as $19.1 billion of the promised $20.5 billion would come from Indian pharmaceutical companies with Sun Pharmaceutical alone accounting for $11.75 billion with its planned acquisition of New Jersey-based Organon & Co.
Participating companies include Aurobindo Pharma Ltd, Biocon Group, Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant Group, Lupin Ltd, Sun Pharmaceutical Industries Ltd, Piramal Pharma Ltd, and Zydus Lifesciences Ltd, the statement noted.
“These investments will support manufacturing and network expansions, new greenfield facilities, and increased research and development, helping expand the supply of essential medicines, address drug shortages, and strengthen the resilience of the U.S. healthcare supply chain,” it said.
12 New investments
The twelve new Investments worth $1.1 billion formally announced at SelectUSA 2026 include four in manufacturing. These are Abhyuday Group’s (Ahmedabad) over $900 million investments across five US sites, creating 1,500 American jobs; Jindal Pipe and Jindal Tubular USA’s investment of $87 million to expand in Texas and Mississippi, creating 140 jobs; Jivo Wellness’ (Delhi) investment of $15 million, creating 50 direct jobs and up to 150 indirect jobs, and Polyhose Inc. investment of $2 million in Los Angeles to support the U.S. shipbuilding industry.
Six investment commitments are from technology, AI, and digital infrastructure. While Sterlite Technologies Ltd. (Mumbai) will invest $100 million, creating up to 500 jobs and supporting AI and telecom infrastructure, investments from the other companies are between $1.5 million and $7.5 million.
MagnoInnovation Lab (Kerala) will invest $2 million to establish US field operations and support energy sector applications. In the field of research and innovation, IIT Madras Global Research Foundation will invest $4.5 million to establish a US research and collaboration hub in California, with plans for an additional East Coast location.
Published on May 6, 2026